F3210-17

F3210-17 is an official guideline established by the U.S. Food and Drug Administration (FDA) for labeling prescription drug products containing benzodiazepines, such as Valium or Xanax. It sets standards for the format, content, and presentation of safety information, warnings, and instructions on medication labels. The goal is to ensure clarity and consistency, helping healthcare providers and patients understand proper use, risks, and precautions associated with these medications, ultimately promoting safe and effective treatment.